# Universal Logistics Holdings, Inc.: financial statements, quarterly

ULH · Nasdaq · CIK 1308208 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ulh.md) · [Financials](/companies/ulh/financials.md) · [Filings](/companies/ulh/filings.md) · [Insiders](/companies/ulh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ulh/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [421](/filings/0000950170-24-123377.md) | [391 d](/filings/0001193125-26-108365.md) | [492](/filings/0000950170-25-067068.md) | [462](/filings/0000950170-25-105075.md) | [427](/filings/0001193125-26-098732.md) | [465 d](/filings/0001193125-26-108365.md) | [382](/filings/0001193125-26-224068.md) | [394](/filings/0001193125-26-349294.md) | [397](/filings/0001193125-26-098732.md) | [385 d](/filings/0001193125-26-108365.md) | [368](/filings/0001193125-26-224068.md) | [379](/filings/0001193125-26-349294.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [36.8](/filings/0000950170-24-123377.md) | [34.1 d](/filings/0001193125-26-108365.md) | [75.1](/filings/0000950170-25-067068.md) | [47.1](/filings/0000950170-25-105075.md) | [42.6](/filings/0001193125-26-098732.md) | [38.3 d](/filings/0001193125-26-108365.md) | [15.7](/filings/0001193125-26-224068.md) | [19.9](/filings/0001193125-26-349294.md) | [(117)](/filings/0001193125-26-098732.md) | [17.5 d](/filings/0001193125-26-108365.md) | [4.8](/filings/0001193125-26-224068.md) | [45.1](/filings/0001193125-26-349294.md) |
| Interest expense | $m | [6.5](/filings/0000950170-24-123377.md) | [6.2 d](/filings/0001193125-26-108365.md) | [6.3](/filings/0000950170-25-067068.md) | [7.8](/filings/0000950170-25-105075.md) | [8.5](/filings/0001193125-26-098732.md) | [11.8 d](/filings/0001193125-26-108365.md) | [11.2](/filings/0001193125-26-224068.md) | [11.6](/filings/0001193125-26-349294.md) | [12.8](/filings/0001193125-26-098732.md) | [13.4 d](/filings/0001193125-26-108365.md) | [12.3](/filings/0001193125-26-224068.md) | [13.1](/filings/0001193125-26-349294.md) |
| Income tax | $m | [7.8](/filings/0000950170-24-123377.md) | [7.2 d](/filings/0001193125-26-108365.md) | [17.7](/filings/0000950170-25-067068.md) | [10.4](/filings/0000950170-25-105075.md) | [8.7](/filings/0001193125-26-098732.md) | [7.1 d](/filings/0001193125-26-108365.md) | [2.0](/filings/0001193125-26-224068.md) | [2.9](/filings/0001193125-26-349294.md) | [(8.6)](/filings/0001193125-26-098732.md) | [3.6 d](/filings/0001193125-26-108365.md) | [(1.1)](/filings/0001193125-26-224068.md) | [8.4](/filings/0001193125-26-349294.md) |
| Net income | $m | [23.0](/filings/0000950170-24-123377.md) | [21.4 d](/filings/0001193125-26-108365.md) | [52.5](/filings/0001193125-26-098732.md) | [30.7](/filings/0001193125-26-098732.md) | [26.5](/filings/0001193125-26-098732.md) | [20.2 d](/filings/0001193125-26-108365.md) | [6.0](/filings/0001193125-26-349294.md) | [8.3](/filings/0001193125-26-349294.md) | [(118)](/filings/0001193125-26-098732.md) | [3.7 d](/filings/0001193125-26-108365.md) | [(3.5)](/filings/0001193125-26-349294.md) | [26.2](/filings/0001193125-26-349294.md) |
| Diluted EPS | $ per share | [0.88](/filings/0000950170-24-123377.md) | not reported | [1.99](/filings/0000950170-25-067068.md) | [1.17](/filings/0000950170-25-105075.md) | [1.01](/filings/0001193125-26-098732.md) | not reported | [0.23](/filings/0001193125-26-224068.md) | [0.32](/filings/0001193125-26-349294.md) | [(4.48)](/filings/0001193125-26-098732.md) | not reported | [(0.13)](/filings/0001193125-26-224068.md) | [0.99](/filings/0001193125-26-349294.md) |
| Basic EPS | $ per share | [0.88](/filings/0000950170-24-123377.md) | not reported | [1.99](/filings/0000950170-25-067068.md) | [1.17](/filings/0000950170-25-105075.md) | [1.01](/filings/0001193125-26-098732.md) | not reported | [0.23](/filings/0001193125-26-224068.md) | [0.32](/filings/0001193125-26-349294.md) | [(4.48)](/filings/0001193125-26-098732.md) | not reported | [(0.13)](/filings/0001193125-26-224068.md) | [0.99](/filings/0001193125-26-349294.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [16.8](/filings/0000950170-23-062086.md) | [12.5](/filings/0000950170-25-040283.md) | [11.1](/filings/0000950170-24-056991.md) | [7.5](/filings/0000950170-24-093989.md) | [11.8](/filings/0000950170-24-123377.md) | [19.4](/filings/0001193125-26-108365.md) | [20.6](/filings/0000950170-25-067068.md) | [24.3](/filings/0000950170-25-105075.md) | [27.4](/filings/0001193125-26-098732.md) | [26.8](/filings/0001193125-26-349294.md) | [17.9](/filings/0001193125-26-224068.md) | [20.3](/filings/0001193125-26-349294.md) |
| Current assets | $m | [389](/filings/0000950170-23-062086.md) | [365](/filings/0000950170-25-040283.md) | [367](/filings/0000950170-24-056991.md) | [383](/filings/0000950170-24-093989.md) | [406](/filings/0000950170-24-123377.md) | [410](/filings/0001193125-26-108365.md) | [389](/filings/0000950170-25-067068.md) | [393](/filings/0000950170-25-105075.md) | [429](/filings/0001193125-26-098732.md) | [383](/filings/0001193125-26-349294.md) | [359](/filings/0001193125-26-224068.md) | [378](/filings/0001193125-26-349294.md) |
| Total assets | $m | [1,259](/filings/0000950170-23-062086.md) | [1,254](/filings/0000950170-25-040283.md) | [1,385](/filings/0000950170-24-056991.md) | [1,472](/filings/0000950170-24-093989.md) | [1,555](/filings/0000950170-24-123377.md) | [1,787](/filings/0001193125-26-108365.md) | [1,800](/filings/0000950170-25-067068.md) | [1,860](/filings/0000950170-25-105075.md) | [1,774](/filings/0001193125-26-098732.md) | [1,772](/filings/0001193125-26-349294.md) | [1,724](/filings/0001193125-26-224068.md) | [1,683](/filings/0001193125-26-349294.md) |
| Current liabilities | $m | [287](/filings/0000950170-23-062086.md) | [260](/filings/0000950170-25-040283.md) | [301](/filings/0000950170-24-056991.md) | [304](/filings/0000950170-24-093989.md) | [297](/filings/0000950170-24-123377.md) | [305](/filings/0001193125-26-108365.md) | [329](/filings/0000950170-25-067068.md) | [308](/filings/0000950170-25-105075.md) | [324](/filings/0001193125-26-098732.md) | [318](/filings/0001193125-26-349294.md) | [318](/filings/0001193125-26-224068.md) | [316](/filings/0001193125-26-349294.md) |
| Long-term debt | $m | [317](/filings/0000950170-23-062086.md) | [311](/filings/0000950170-25-040283.md) | [341](/filings/0000950170-24-056991.md) | [404](/filings/0000950170-24-093989.md) | [472](/filings/0000950170-24-123377.md) | [670](/filings/0001193125-26-108365.md) | [645](/filings/0000950170-25-067068.md) | [698](/filings/0000950170-25-105075.md) | [719](/filings/0001193125-26-098732.md) | [683](/filings/0001193125-26-349294.md) | [634](/filings/0001193125-26-224068.md) | [594](/filings/0001193125-26-349294.md) |
| Current portion of debt | $m | [69.9](/filings/0000950170-23-062086.md) | [70.7](/filings/0000950170-25-040283.md) | [73.5](/filings/0000950170-24-056991.md) | [79.9](/filings/0000950170-24-093989.md) | [85.7](/filings/0000950170-24-123377.md) | [88.8](/filings/0001193125-26-108365.md) | [91.6](/filings/0000950170-25-067068.md) | [97.3](/filings/0000950170-25-105075.md) | [105](/filings/0001193125-26-098732.md) | [115](/filings/0001193125-26-349294.md) | [116](/filings/0001193125-26-224068.md) | [98.5](/filings/0001193125-26-349294.md) |
| Shareholders' equity | $m | [510](/filings/0000950170-24-123377.md) | [532](/filings/0001193125-26-108365.md) | [584](/filings/0001193125-26-098732.md) | [609](/filings/0001193125-26-098732.md) | [631](/filings/0001193125-26-098732.md) | [647](/filings/0001193125-26-349294.md) | [646](/filings/0001193125-26-349294.md) | [654](/filings/0001193125-26-349294.md) | [535](/filings/0001193125-26-098732.md) | [540](/filings/0001193125-26-349294.md) | [539](/filings/0001193125-26-349294.md) | [561](/filings/0001193125-26-349294.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [56.2 d](/filings/0000950170-24-123377.md) | [49.0 d](/filings/0001193125-26-108365.md) | [36.9](/filings/0000950170-25-067068.md) | [9.6 d](/filings/0000950170-25-105075.md) | [6.2 d](/filings/0001193125-26-098732.md) | [59.7 d](/filings/0001193125-26-108365.md) | [84.3](/filings/0001193125-26-224068.md) | [25.7 d](/filings/0001193125-26-349294.md) | [25.9 d](/filings/0001193125-26-098732.md) | [47.1 d](/filings/0001193125-26-108365.md) | [33.4](/filings/0001193125-26-224068.md) | [40.5 d](/filings/0001193125-26-349294.md) |
| Capital expenditure | $m | [112 d](/filings/0000950170-24-123377.md) | [48.5 d](/filings/0001193125-26-108365.md) | [68.6](/filings/0000950170-25-067068.md) | [77.1 d](/filings/0000950170-25-105075.md) | [65.1 d](/filings/0001193125-26-098732.md) | [40.8 d](/filings/0001193125-26-108365.md) | [52.6](/filings/0001193125-26-224068.md) | [84.3 d](/filings/0001193125-26-349294.md) | [54.5 d](/filings/0001193125-26-098732.md) | [32.9 d](/filings/0001193125-26-108365.md) | [9.6](/filings/0001193125-26-224068.md) | [13.3 d](/filings/0001193125-26-349294.md) |
| Dividends paid | $m | [2.8 d](/filings/0000950170-24-123377.md) | [2.8 d](/filings/0001193125-26-108365.md) | [2.8](/filings/0000950170-25-067068.md) | [2.8 d](/filings/0000950170-25-105075.md) | [2.8 d](/filings/0001193125-26-098732.md) | [2.8 d](/filings/0001193125-26-108365.md) | [2.8](/filings/0001193125-26-224068.md) | [2.8 d](/filings/0001193125-26-349294.md) | [2.8 d](/filings/0001193125-26-098732.md) | [2.8 d](/filings/0001193125-26-108365.md) | [2.8](/filings/0001193125-26-224068.md) | [2.8 d](/filings/0001193125-26-349294.md) |
| Share repurchases | $m | [0.1 d](/filings/0000950170-24-123377.md) | [0.0 d](/filings/0001193125-26-108365.md) | not reported | not reported | [0.0 d](/filings/0001193125-26-098732.md) | [0.0 d](/filings/0001193125-26-108365.md) | not reported | not reported | [0.0 d](/filings/0001193125-26-098732.md) | [0.0 d](/filings/0001193125-26-108365.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [26.3](/filings/0000950170-23-062086.md) | [26.3](/filings/0000950170-24-056991.md) | [26.3](/filings/0000950170-24-093989.md) | [26.3](/filings/0000950170-24-123377.md) | [26.3](/filings/0000950170-25-067068.md) | [26.4](/filings/0000950170-25-105075.md) | [26.4](/filings/0001193125-26-098732.md) | [26.3](/filings/0001193125-26-224068.md) | [26.3](/filings/0001193125-26-349294.md) | [26.3](/filings/0001193125-26-098732.md) | [26.4](/filings/0001193125-26-224068.md) | [26.4](/filings/0001193125-26-349294.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 26,367,805 at 2026-08-07, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349294.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.